SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-265755
Filing Date
2022-10-20
Accepted
2022-10-20 09:12:08
Documents
15
Period of Report
2022-10-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d414605d8k.htm   iXBRL 8-K 25084
2 EX-99.1 d414605dex991.htm EX-99.1 28495
7 GRAPHIC g414605g1019081341130.jpg GRAPHIC 3675
  Complete submission text file 0001193125-22-265755.txt   222414

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20221020.xsd EX-101.SCH 3909
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20221020_def.xml EX-101.DEF 13283
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20221020_lab.xml EX-101.LAB 21865
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20221020_pre.xml EX-101.PRE 14180
9 EXTRACTED XBRL INSTANCE DOCUMENT d414605d8k_htm.xml XML 5145
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 221320046
SIC: 2836 Biological Products, (No Diagnostic Substances)